Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)

Clinical trial NCT05567757 · COMPLETED

Trial details

NCT number: NCT05567757
Sponsor: Vascudyne, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2022-10-04
Primary completion: 2025-03-30
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.